BridgeBio Oncology Therapeutics, Inc. (BBOT)
Market Open
15 Jun, 15:20
NASDAQ (NMS) NASDAQ (NMS) Primary $
7. 73
-0.02
-0.2787%
$
581.58M Market Cap
- P/E Ratio
- Div Yield
42,250 Volume
- Eps
$ 7.75
Previous Close Want to track BBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BBOT Earnings Reports FAQ
What is the earnings per share (EPS) for BBOT?
EPS data for BBOT is currently not available, as BridgeBio Oncology Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
BridgeBio Oncology Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
BridgeBio Oncology Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BridgeBio Oncology Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BBOT at this time, as BridgeBio Oncology Therapeutics, Inc has no recent EPS data to calculate it.
